ID: ALA316976

Max Phase: Preclinical

Molecular Formula: C10H15FNO+

Molecular Weight: 184.23

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[N+](C)(CCO)c1ccc(F)cc1

Standard InChI:  InChI=1S/C10H15FNO/c1-12(2,7-8-13)10-5-3-9(11)4-6-10/h3-6,13H,7-8H2,1-2H3/q+1

Standard InChI Key:  GWVXEQBIKFHHJK-UHFFFAOYSA-N

Associated Targets(non-human)

Creatine transporter 104 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 184.23Molecular Weight (Monoisotopic): 184.1132AlogP: 1.38#Rotatable Bonds: 3
Polar Surface Area: 20.23Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.95CX Basic pKa: CX LogP: -2.51CX LogD: -2.51
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.70Np Likeness Score: 0.00

References

1. Geldenhuys WJ, Lockman PR, McAfee JH, Fitzpatrick KT, Van der Schyf CJ, Allen DD..  (2004)  Molecular modeling studies on the active binding site of the blood-brain barrier choline transporter.,  14  (12): [PMID:15149650] [10.1016/j.bmcl.2004.04.020]

Source